Posts by Luke

The Trump administration restricted NIAID officials from communicating with the World Health Organization during an active Ebola epidemic. The cost is not diplomatic — it is operational, and ordinary people will pay it.

Reuters reports the FDA’s looser vape and nicotine-pouch policy could benefit hundreds of products after heavy tobacco-industry lobbying.

The FDA’s sudden nicotine guidance is a reminder that public-health trust breaks when scientific review looks like it can be rerouted by politics and lobbying.

Reuters reports more than 900 suspected Ebola cases in the Democratic Republic of Congo, including 101 confirmed cases. The story is not panic; it is whether public-health institutions still have enough trust to move fast.

A 50,000-person evacuation over an overheating chemical tank shows how public trust is built before the emergency, not during it.

Philadelphia officials warned former patients of a Rittenhouse Square dental practice to get tested for HIV, hepatitis B, and hepatitis C after infection-control concerns, turning a local clinic story into a public-trust problem.

The anti-weaponization fund may be sold as relief for abuse, but its structure turns legitimate grievances into a fight over taxpayer money and executive power.

Gilead’s first U.S.-approved hepatitis D treatment fills a real medical gap, but accelerated approval also puts public trust on the follow-through study.

Hospitals say CVS diverted $250 million in 340B savings, turning a safety-net drug program into another fight over healthcare middlemen.

New U.S. Ebola screening rules and unrest around a DRC treatment center show that outbreak response depends as much on public trust and execution capacity as on official restrictions.